Literature DB >> 9128202

Elevated 12-lipoxygenase activity in the spontaneously hypertensive rat.

M Sasaki1, M T Hori, T Hino, M S Golub, M L Tuck.   

Abstract

We have previously demonstrated that administration of inhibitors of the lipoxygenase (LO) pathway of arachidonic acid metabolism lowers blood pressure in hypertensive rats. In addition, we have shown that LO inhibition attenuates pressor agonist-induced vascular reactivity in vitro and calcium mobilization in cultured vascular smooth muscle cells (VSMC). To further elucidate the relationship between elevated LO activity and hypertension, 4, 8, and 12 week old hypertensive SHR were compared with age-matched Wistar-Kyoto (WKY) rats for plasma 12(S)-hydroxyeicosatetraenoic acid (12-HETE) concentration. 12-HETE levels were significantly elevated in the SHR compared to the WKY (SHR elevated by 154%, 159%, and 272% compared to WKY at 4, 8, and 12 weeks, respectively, P < .01 for all ages). There were no differences in plasma potassium levels between SHR and WKY at any of the ages tested. Plasma aldosterone levels and plasma renin activity were in the normal range at the three ages. At 12 weeks of age, both serum (4.72 +/- 0.23 v 2.18 +/- 0.33 microg/mL, P < .01), and aortic smooth muscle 12-HETE levels (0.94 +/- 0.09 v 0.66 +/- 0.08 microg/mg protein, P < .05) were elevated in SHR compared with WKY. The 12 week old SHR were given a bolus of the LO inhibitor 5,8,11-eicosatriynoic acid (ETI, 7 mg/kg, intravenously) and blood pressure measured after 20 min. ETI reduced mean systolic blood pressure from 175.8 +/- 4.2 to 141.6 +/- 5.9 mm Hg (P < .05). To investigate these effects of HETEs, cultured vascular smooth muscle cells were pretreated for 1 min with 12(S)HETE and then challenged with angiotensin II (AngII). The addition of 12(S)HETE increased AngII-induced intracellular calcium levels in normal cultured rat vascular smooth muscle cells by 78% compared to vehicle (P < .05). Thus, LO products, which are high in SHR, may contribute to vascular tone through alterations in the intracellular calcium signal by potentiating calcium responses to pressors such as Ang II.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9128202

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  12 in total

Review 1.  Functional and pathological roles of the 12- and 15-lipoxygenases.

Authors:  Anca D Dobrian; David C Lieb; Banumathi K Cole; David A Taylor-Fishwick; Swarup K Chakrabarti; Jerry L Nadler
Journal:  Prog Lipid Res       Date:  2010-10-21       Impact factor: 16.195

2.  CCL5 upregulates IL-10 expression and partially mediates the antihypertensive effects of IL-10 in the vascular smooth muscle cells of spontaneously hypertensive rats.

Authors:  Hye Young Kim; Hye Ju Cha; Hee Sun Kim
Journal:  Hypertens Res       Date:  2015-05-14       Impact factor: 3.872

3.  Lipoxygenase products in the urine correlate with renal function and body temperature but not with acute transplant rejection.

Authors:  Stephan W Reinhold; Thomas Scherl; Benjamin Stölcker; Tobias Bergler; Ute Hoffmann; Christian Weingart; Miriam C Banas; Dmitrij Kollins; Martin C Kammerl; Bernd Krüger; Bernhard Kaess; Bernhard K Krämer; Bernhard Banas
Journal:  Lipids       Date:  2012-12-29       Impact factor: 1.880

4.  Catalytic consumption of nitric oxide by 12/15- lipoxygenase: inhibition of monocyte soluble guanylate cyclase activation.

Authors:  M J Coffey; R Natarajan; P H Chumley; B Coles; P R Thimmalapura; M Nowell; H Kühn; M J Lewis; B A Freeman; V B O'Donnell
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-26       Impact factor: 11.205

5.  2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1.

Authors:  Seyhan Sahan-Firat; Brett L Jennings; Fariborz A Yaghini; Chi Young Song; Anne M Estes; Xiao R Fang; Nasreen Farjana; Amir I Khan; Kafait U Malik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-09-17       Impact factor: 4.733

6.  Inhibition of renin release by arachidonic acid metabolites, 12(s)-HPETE and 12-HETE: role of TRPV1 channels.

Authors:  Chaoqin Xie; Donna H Wang
Journal:  Endocrinology       Date:  2011-08-16       Impact factor: 4.736

7.  Elevated endothelial nitric oxide bioactivity and resistance to angiotensin-dependent hypertension in 12/15-lipoxygenase knockout mice.

Authors:  Peter B Anning; Barbara Coles; Alexandra Bermudez-Fajardo; Patricia E M Martin; Bruce S Levison; Stanley L Hazen; Colin D Funk; Hartmut Kühn; Valerie B O'Donnell
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

8.  12(S)-hydroperoxyeicosatetraenoic acid (12-HETE) increases mitochondrial nitric oxide by increasing intramitochondrial calcium.

Authors:  Rafal R Nazarewicz; Woineshet J Zenebe; Arti Parihar; Mordhwaj S Parihar; Michael Vaccaro; Cameron Rink; Chandan K Sen; Pedram Ghafourifar
Journal:  Arch Biochem Biophys       Date:  2007-09-29       Impact factor: 4.013

Review 9.  Cellular mediators of renal vascular dysfunction in hypertension.

Authors:  Bharathy Ponnuchamy; Raouf A Khalil
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-02-18       Impact factor: 3.619

10.  IL-8/CXCL8 Upregulates 12-Lipoxygenase Expression in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats.

Authors:  Jung Hae Kim; Young Jin Kang; Hee Sun Kim
Journal:  Immune Netw       Date:  2009-06-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.